Market revenue in 2023 | USD 118.3 million |
Market revenue in 2030 | USD 176.5 million |
Growth rate | 5.9% (CAGR from 2023 to 2030) |
Largest segment | Biologics |
Fastest growing segment | Biologics |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications |
Key market players worldwide | ConvaTec Group PLC, 3M Co, Coloplast A/S ADR, Smith & Nephew PLC, Medtronic PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to diabetic foot ulcer treatment market will help companies and investors design strategic landscapes.
Biologics was the largest segment with a revenue share of 36.43% in 2023. Horizon Databook has segmented the Sweden diabetic foot ulcer treatment market based on wound care dressings, biologics, therapy devices, antibiotic medications covering the revenue growth of each sub-segment from 2018 to 2030.
Rising prevalence of chronic diseases, especially diabetes, and growing geriatric population are the major driving factors for the market. For instance, as per Statistics Sweden (SCB), the population aged 80 years and above is expected to increase by 50% by 2028.
However, absence of major market players in Sweden due to lack of awareness about diabetic foot ulcer treatments may hinder the market growth over the forecast period. The medical devices manufacturing industry in Sweden is comparatively small and employs roughly 18,000 people.
Domestic companies include small- to mid-sized manufacturers. However, several multinational medical device companies have established subsidiaries in Sweden. For instance, companies such as Mölnlycke Health Care AB are headquartered in Sweden.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden diabetic foot ulcer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Sweden diabetic foot ulcer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account